Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1

Interventions

Cytarabine 56Etoposide 24Daunorubicin 22Filgrastim 18Busulfan 16fludarabine phosphate 14Mitoxantrone 14Idarubicin 14Cyclophosphamide 14Peripheral Blood Stem Cell Transplantation 12tipifarnib 11Gemtuzumab 11Flow Cytometry 9Cyclosporine 9Antilymphocyte Serum 9sargramostim 8Methotrexate 8Clofarabine 8Gene Expression Profiling 7Topotecan 6Radiotherapy 6Azacitidine 6valspodar 5alvocidib 5aldesleukin 5Melphalan 5Whole-Body Irradiation 4Observation 4Methylprednisolone 4Granulocyte Colony-Stimulating Factor 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Erythroblastic, Acute × choline magnesium trisalicylate × Clear all
NCT02144675 2021-08-24

Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia

Rutgers, The State University of New Jersey

Phase 2 Completed
27 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡